Cordavis makes strategic investments to bring pharmaceutical products to the U.S. market to increase competition and lower costs. Cordavis partners with manufacturers and payors to deliver: • Sustainable cost savings for payors and patients • A reliable and predictable supply chain that minimizes disruption for patients • A responsible and viable long-term approach to deliver value and affordable products Our partnerships create a vibrant and competitive marketplace, allowing us to expand our investments in future products to shape tomorrow's health care, today. Cordavis is a wholly owned subsidiary of CVS Health.
| Website | https://www.cordavis.com/ |
| Employees | 42 (39 on RocketReach) |
| Founded | 2023 |
| Industry | Pharmaceutical Manufacturing |
| Keywords | Biosimilars, Pharmaceutical, Pharmaceutical Manufacturing, Drug Manufacturing, Fda Approved Drugs, Pharmaceutical Production, High Quality Drugs, Drug Development, Drug Production, Drug Commercialization, Generic Drugs, Biotechnology, Biologics, Healthcare, Affordable Medicine, Health Products |
| Competitors | Siemens Healthineers, Roche, Thermo Fisher Scientific, Abbott, BD, Mayo Clinic Laboratories, Quest Diagnostics, Labcorp, Eurofins, PerkinElmer, Inc. +43 more (view full list) |
Looking for a particular Cordavis employee's phone or email?
Jeff Martin is the President of Cordavis.
39 people are employed at Cordavis.